NA
FBT icon

Navellier & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Navellier & Associates’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Sell
6,678
-1,724
-21% -$357K 0.14% 127
2025
Q4 		$1.74M Sell
8,402
-3,256
-28% -$651K 0.19% 113
2025
Q3 		$2.09M Buy
+11,658
New +$1.99M 0.21% 108
2024
Q4 		– Sell
-17,159
Closed -$2.95M – 343
2024
Q3 		$2.95M Sell
17,159
-4,147
-19% -$686K 0.4% 67
2024
Q2 		$3.28M Buy
+21,306
New +$3.2M 0.39% 65
2023
Q4 		– Sell
-23,276
Closed -$3.41M – 333
2023
Q3 		$3.41M Buy
23,276
+375
+2% +$57.1K 0.58% 54
2023
Q2 		$3.51M Buy
+22,901
New +$3.57M 0.68% 57
2021
Q2 		– Sell
-36,421
Closed -$5.85M – 314
2021
Q1 		$5.85M Buy
+36,421
New +$6.24M 1.05% 29
2019
Q2 		– Sell
-127,463
Closed -$19.2M – 286
2019
Q1 		$19.2M Buy
+127,463
New +$18.3M 2.98% 5
2018
Q4 		– Sell
-170,264
Closed -$27M – 252
2018
Q3 		$27M Buy
170,264
+134
+0.1% +$20.3K 3.49% 2
2018
Q2 		$23.8M Sell
170,130
-715
-0.4% -$98.2K 3.32% 1
2018
Q1 		$22.7M Buy
+170,845
New +$23.3M 3.44% 1
2017
Q4 		– Sell
-3,210
Closed -$398K – 301
2017
Q3 		$398K Sell
3,210
-156,498
-98% -$18.5M 0.08% 168
2017
Q2 		$18.2M Buy
+159,708
New +$17.2M 2.72% 2
2017
Q1 		– Sell
-67,365
Closed -$6.12M – 288
2016
Q4 		$6.12M Buy
67,365
+21,937
+48% +$2.05M 1.01% 24
2016
Q3 		$4.53M Buy
+45,428
New +$4.46M 0.65% 54
2015
Q2 		– Sell
-18,248
Closed -$2.16M – 363
2015
Q1 		$2.16M Buy
+18,248
New +$2.06M 0.2% 60
2014
Q4 		– Sell
-16,035
Closed -$1.47M – 337
2014
Q3 		$1.47M Buy
+16,035
New +$1.39M 0.07% 72

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Navellier & Associates's FBT Position: Q1 2026 in Review

Navellier & Associates reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 21% in Q1 2026, selling an estimated $357K and leaving 6,678 shares worth $1.34M. The position accounts for 0.14% of the portfolio, ranked #127.

Navellier & Associates first reported a position in FBT in Q3 2014 and has held it in 18 quarters since. The position peaked at $27M in Q3 2018. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Navellier & Associates held 6,678 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.34M as of Q1 2026.
  • Navellier & Associates sold 1,724 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $357K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.14% of Navellier & Associates's portfolio in Q1 2026, its #127 holding.
  • Navellier & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2014 and has held it in 18 quarters since.
  • Navellier & Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $27M in Q3 2018.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.